指南与共识细菌感染、耐药与抗菌药物

金黄色葡萄球菌甲氧西林耐药机制与命名:ISAC-SAWG与ESCMID-ESGS立场声明

Mechanism and nomenclature of methicillin resistance in Staphylococcus aureus and implications for testing interpretation and management: a position statement on behalf of the Staphylococcus aureus working groups ISAC-SAWG and ESCMID-ESGS.
指南 / 共识 · Clin Microbiol Infect · 2026-10-12

国际抗微生物化疗学会与欧洲临床微生物和感染病学会的金黄色葡萄球菌工作组发布立场声明,针对金黄色葡萄球菌对甲氧西林/苯唑西林敏感性降低或耐药的多种机制提出统一命名分类。声明将耐药分为mec介导的MRSA、缺乏mec的MRSA(含β-内酰胺酶高产和PBP修饰亚型)以及mec阳性但苯唑西林敏感菌株,旨在消除临床沟通与文献中的歧义,并随新机制出现更新定义。

要点

  • mec介导MRSA可呈异质性耐药表达。
  • 缺乏mec的MRSA不宜常规区分机制,统称缺乏mec的MRSA。
  • β-内酰胺酶高产菌对苯唑西林低水平耐药,多数对头孢西丁敏感。

核心结论

  • 工作组提出金黄色葡萄球菌甲氧西林/苯唑西林耐药统一命名分类,以消除临床沟通与文献歧义。

研究设计与样本

  • 国际抗微生物化疗学会与欧洲临床微生物和感染病学会金黄色葡萄球菌工作组立场声明。

主要发现

  • mec介导MRSA由mecA、mecB或mecC介导,可呈异质性耐药表达。
  • 缺乏mec的MRSA对头孢西丁和/或苯唑西林耐药且mec阴性,无异质性耐药,可分β-内酰胺酶高产和PBP修饰。
  • β-内酰胺酶高产菌对苯唑西林低水平耐药,多数对头孢西丁敏感。
  • PBP1-4修饰菌在常规实验室多表现为头孢西丁耐药。
  • mec阳性但苯唑西林敏感菌株因mec基因突变、缺失或插入而表型敏感。

关键数值与推荐

  • mec介导MRSA:由mecA、mecB或mecC介导,可异质性表达。
  • 缺乏mec的MRSA:头孢西丁和/或苯唑西林耐药但mec阴性,无异性耐药。
  • β-内酰胺酶高产菌:对苯唑西林低水平耐药,多数对头孢西丁敏感。
  • PBP修饰菌:常规实验室多表现为头孢西丁耐药。
  • mec阳性但苯唑西林敏感:携带mec基因但表型对苯唑西林/头孢西丁敏感。

临床怎么用

  • 常规实验室难以区分缺乏mec的MRSA亚型时,建议使用缺乏mec的MRSA名称。
  • 机制明确后,β-内酰胺酶高产菌应命名为高产β-内酰胺酶金黄色葡萄球菌,取代边缘型苯唑西林耐药金黄色葡萄球菌。
  • PBP修饰菌建议继续命名为修饰金黄色葡萄球菌。

局限性

  • 缺乏mec的MRSA两种机制在常规实验室不易区分。
  • 新耐药机制出现时定义需相应更新。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Beyond mec-mediated resistance, Staphylococcus aureus has developed complex resistance mechanisms against antistaphylococcal β-lactam antibiotics. The scientific community lacks a unified consensus on the nomenclature/clinical implications of these mechanisms. OBJECTIVES: This position statement by the members of Staphylococcus Working Groups of the International Society of Antimicrobial Chemotherapy and the European Society of Clinical Microbiology and Infectious Diseases propose a set of names for various types of methicillin/oxacillin reduced susceptibility/resistance in S. aureus. CONTENT: The Working Groups propose the following categorization: (1) mec-mediated methicillin-resistant S. aureus: This is due to mec (mecA or mecB or mecC)-mediated resistance. They can exhibit heteroresistant expression to methicillin. (2) Methicillin-resistant S. aureus lacking mec: Isolates are cefoxitin and/or oxacillin-resistant but mec-negative, and do not show heteroresistance. They can be subdivided into (2a) hyperproduction of β-lactamase and (2b) modifications of natural penicillin-binding proteins. Importantly, these mechanisms cannot easily be differentiated in routine laboratories. If the resistance mechanism is not fully characterized, using the name methicillin-resistant lacking mec is suggested. Isolates with hyperproduction of β-lactamase show low-level resistance to oxacillin, but most isolates test susceptible to cefoxitin. When the mechanism is characterized, we propose that they should be named hyper- β-lactamase-producing S. aureus instead of the hitherto used term borderline oxacillin-resistant S. aureus. For isolates with reistance due to modifications of the penicillin-binding proteins 1-4 in S. aureus, it is proposed to continue to name these modified S. aureus. Modified S. aureus isolates in routine diagnostic laboratories most commonly present as cefoxitin-resistant. (3) Oxacillin-susceptible mec-positive S. aureus: Strains carry a mec gene but harbour mutations, deletions, or insertion rendering them phenotypically susceptible to oxacillin/cefoxitin. IMPLICATIONS: The proposed changes clarify methicillin resistance nomenclature in S. aureus, removing current ambiguity from clinical communication and literature. As novel methicillin resistance mechanisms emerge in S. aureus, the definition must be updated accordingly.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Saeed K, Mason-Slingerland BCGC, David MZ, et al. Mechanism and nomenclature of methicillin resistance in Staphylococcus aureus and implications for testing interpretation and management: a position statement on behalf of the Staphylococcus aureus working groups ISAC-SAWG and ESCMID-ESGS. Clin Microbiol Infect. 2026. PMID: 42863756. doi:10.1016/j.cmi.2026.09.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。